Research and experimental development on natural sciences and engineering
VAXXINOVA NORWAY AS
Revenue 2025
NOK 17.7m
Operating profit
NOK −35.5m
Equity
NOK 893,000
Incorporated
2010
Employees
23
Share capital
NOK 100,000
Organisation
Employees
23
Established
2010-01-29
Industry code
72.100
Legal form
AS
Group structure
Eier · 100.0%
VAXXINOVA INTERNATIONAL B.V.
Company
VAXXINOVA NORWAY AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Forskning og utvikling, salg, markedsføring og teknisk støtte relatert til veterinærmedisinske produkter og tjenester, spesielt biologiske produkter for akvakulturindustrien.
Business address
Kong Christian Fredriks plass 3, 5006 BERGEN
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.